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FIGURE 1. Anterolateral view of left ventricle and mitral subvalvular apparatus.
Letters to the EditorMoreover, all pulmonary vein orifices
cannot be visualized from this view;
only right superior and inferior pulmo-
nary vein orifices can be visualized.2
As a second point, an ideal annulo-
plasty technique should primarily
address the septolateral diameter
with less impact on transverse diam-
eter, aiming to avoid distorting both
leaflets, especially in the case of func-
tional mitral regurgitation,3 where
type IIIb dysfunction is observed if
fibrotic changes do not exist. It can
be speculated that papillary muscle
sling placement will fail to reduce
equatorial septolateral dimensionThe Journalwhile exerting its main effect on trans-
verse diameter when spatial locations
of papillary muscles in left ventricle
are taken into account. Because septo-
lateral dimensional change is one of
the most important determinants of
recurrence after mitral valve repair,4,5
papillary muscle sling placement
technique seems not to add much to
the conventional downsizing ring
annuloplasty when long-term out-
comes are evaluated.
In conclusion, correction of the
illustration as shown in Figure 1 can
be useful to avoid misunderstandings.
We appreciate the authors for theirof Thoracic and Cardiovascular Surgerefforts and thank them for sharing
their experiences.
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We greatly appreciate Tavlasoglus
and colleagues’ interest in our recent
publication, which reported the safety
and feasibility of the placement of a
papillary muscle sling during mini-
mally invasive mitral valve repair
for functional mitral regurgitation
(MR).1 We appreciate their illustra-
tion, because ours was more of ay c Volume 146, Number 5 1309
Letters to the Editorgeneral representation. We respect-
fully disagree, however, with most of
their comments and conclusions.
Their statement that ‘‘an ideal an-
nuloplasty technique should primarily
address the septolateral diameter’’ im-
plies that annular dilatation plays an
important role in the cause of the
MR and that addressing this issue
should solve the problem. This
thinking is erroneous. Most patients
with functional MR have a structur-
ally normal mitral valve; however,
the valve is incompetent because of
left ventricular remodeling that has
disturbed the relationship between
the subvalvular apparatus and the
mitral valve leaflets. In vitro models
have demonstrated that the coaptation
length of the mitral valve leaflets is
sufficiently redundant, permitting an
approximate 1.8-fold increase in
annular area before MR develops.2
This means that the relative contribu-
tion of annular enlargement to the
overall regurgitant burden in func-
tional MR is minor relative to that im-
parted by the tethering forces on the
mitral valve leaflets as a result of the
apical and posterolateral displacement
of the papillary muscles. The main
cause of MR is thus leaflet malapposi-
tion, which is the failure of the leaflets
to close on the same plane, as opposed
to leaflet malcoaptation, which is the
failure of the leaflets to meet. What
this means is that functional MR is
mainly a ventricular problem, rather
than a valve problem.
To support their premise that a
papillary muscle sling would not
work, Tavlasoglus and colleagues state
that ‘‘septolateral dimension change is
one of the most important determi-
nants of recurrence after mitral valve
repair’’ and cite references from Mai-
sano and coworkers3 and Tahta and as-
sociates.4 Neither of these references1310 The Journal of Thoracic andsupports their comments; in fact, Mai-
sano and coworkers3 clearly stated that
‘‘a significant correlation was found
between recurrent MR and declining
left ventricular function,’’ that in func-
tional MR ‘‘mitral valve annuloplasty
is simply a temporizing measure,’’
and that ‘‘a simple ring annuloplasty
does not definitively restore’’ the
optimal left ventricular geometry. No-
where do they make any comment to
support the statements of Tavlasoglus
and colleagues. Tahta and associates4
reported on a study comparing com-
plete annuloplasty rings with partial
rings. They did not state that a septolat-
eral dimension change was the cause
of recurrent MR. Data from the
Cleveland Clinic have demonstrated
that in patients undergoing undersized
annuloplasty for functional MR, 28%
will have moderate or more MR
develop 6 months postoperatively. It
is believed that the recurrent MR is
caused by the underlying process of
left ventricular dilatation from left
ventricular remodeling, which con-
tinues despite having ‘‘fixed’’ the
valve.
Because the recurrent MR rates are
so high with an undersized annulo-
plasty technique, many authors are
exploring other adjunctive procedures
to reduce this recurrence. This includes
restraint devices such as the Coapsys
system and the Acorn Corcap, which
are intended to improve left ventricular
function by reducing wall stress, pro-
vide passive diastolic support, and
reduce continued left ventricular dila-
tation. Along similar lines, papillary
muscle sling placement is being evalu-
ated to reduce the progression of left
ventricular remodeling. Work by
Hvass and Joudinaud5 has demon-
strated that placement of a papillary
muscle sling in patients undergoing
annuloplasty for functional MR isCardiovascular Surgery c November 20associated with improvement in ejec-
tion fraction, reduction in the end-
diastolic and end-systolic diameters,
and reduction in the mean pulmonary
arterial systolic pressure. Our results
have been similar to theirs. Although
the optimal approach to the manage-
ment of individual patients with
ischemicMR has not been established,
we believe that an undersized annulo-
plasty approach is not enough, and
other techniques need to be explored.
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